Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,672.55
(
-0.65%
)
US TECH 100
23,958.80
(
-0.72%
)
Dow Jones
46,557.52
(
-0.93%
)
Brent Oil
105.29
(
4.61%
)
Bitcoin
71,663.99
(
-3.08%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 140561

Friday, 04/20/2012 5:36:38 PM

Friday, April 20, 2012 5:36:38 PM

Post# of 257253
Inasmuch as Eliquis’ PDUFA date is 6/28/12, the canceled meeting in May almost certainly means that Eliquis will not have an FDA advisory panel. Given the strength of the Eliquis data in both the ARISTOTLE (#msg-66604305, #msg-66610218) and AVERROES (#msg-54576974) studies, the cancellation of the advisory panel is presumably bullish.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today